CIK 0001228627 · Non-accelerated filer<br>Smaller reporting company
Opus Genetics, Inc.
Sign in to watch- Ticker
- IRD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 113516358
- Phone
- (984) 884-6030
- Business address
- 8 DAVIS DRIVE, SUITE 220, DURHAM, NC, 27713
- Former names
- Ocuphire Pharma, Inc., REXAHN PHARMACEUTICALS, INC., CORPORATE ROAD SHOW DOT COM INC, FERRARO FRANK
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,211,769
- in 7 filings, $50K under 10b5-1 plans
Net −$3,211,769. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Foundation Fighting Blindness Retinal Degeneration Fund −$2.8M Director sold 15% of stake
- Gagnon Robert E. −$177K Chief Financial Officer sold 7% of stake
- Magrath George −$145K Chief Executive Officer sold 2% of stake
- YERXA BENJAMIN R −$117K President sold 5% of stake
- SCHACHLE JOSEPH K −$17K Chief Operating Officer sold 2% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-05-19 | Sooch Mina President and CEO | Purchase | +12,500 | $2.07 | $26K | 412,522 |
| 2022-04-08 | Pepose Jay Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2022-04-01 | Benton Susan Director | Grant or award | +3,395 | 32,455 | ||
| 2022-04-01 | Rodgers Richard J Director | Grant or award | +4,629 | 40,623 | ||
| 2022-01-28 | Hoffmann Bernhard VP of Corp. Dev. & Ops & Sec. | Grant or award · Employee Stock Option (right to buy) | +42,500 | 42,500 | ||
| 2022-01-28 | Sooch Mina President and CEO | Grant or award · Employee Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2022-01-28 | Zaremba Rabourn Amy VP of Finance | Grant or award · Employee Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2022-01-03 | Rodgers Richard J Director | Grant or award | +4,021 | 35,994 | ||
| 2022-01-03 | Benton Susan Director | Grant or award | +2,949 | 29,060 | ||
| 2021-12-13 | Pepose Jay Director | Purchase | +8,250 | $3.65 | $30K | 22,994 |
| 2021-11-18 | MANUSO JAMES S J Director | Purchase | +2,000 | $3.50 | $7K | 16,570 |
| 2021-10-01 | Rodgers Richard J Director | Grant or award | +2,912 | 31,973 | ||
| 2021-10-01 | Benton Susan Director | Grant or award | +2,135 | 26,111 | ||
| 2021-09-13 | Pepose Jay Director | Purchase | +12,631 | $4.75 | $60K | 14,744 |
| 2021-09-02 | Benton Susan Director | Purchase | +20,000 | $4.57 | $91K | 23,976 |
| 2021-07-01 | Benton Susan Director | Grant or award | +2,083 | 3,976 | ||
| 2021-07-01 | Rodgers Richard J Director | Grant or award | +2,840 | 29,061 | ||
| 2021-06-07 | Gallagher Cam Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2021-06-07 | Ainsworth Sean Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2021-06-07 | Pepose Jay Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 |
Page 11 of 15 · 283 trades